"New study shows metformin given during acute COVID-19 infection reduced risk of clinician-diagnosed long COVID by 50%"
"At 6 months, participants who received metformin experienced a 50% relative reduction in the risk of clinician-diagnosed long COVID compared with those receiving placebo"
New findings from the ACTIV-6 randomized clinical trial provide important confirmation of prior clinical trial results that metformin, a widely available and inexpensive medication with an established...
